NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Journal Article (Journal Article)

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.

Full Text

Duke Authors

Cited Authors

  • Adelstein, D; Gillison, ML; Pfister, DG; Spencer, S; Adkins, D; Brizel, DM; Burtness, B; Busse, PM; Caudell, JJ; Cmelak, AJ; Colevas, AD; Eisele, DW; Fenton, M; Foote, RL; Gilbert, J; Haddad, RI; Hicks, WL; Hitchcock, YJ; Jimeno, A; Leizman, D; Lydiatt, WM; Maghami, E; Mell, LK; Mittal, BB; Pinto, HA; Ridge, JA; Rocco, J; Rodriguez, CP; Shah, JP; Weber, RS; Witek, M; Worden, F; Yom, SS; Zhen, W; Burns, JL; Darlow, SD

Published Date

  • June 2017

Published In

Volume / Issue

  • 15 / 6

Start / End Page

  • 761 - 770

PubMed ID

  • 28596256

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2017.0101


  • eng

Conference Location

  • United States